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A B S T R A C T
Here we evaluated the eﬀects of human retinal microvascular endothelial cells (hREC) on mature human
embryonic stem cell (hESC) derived retinal pigment epithelial (RPE) cells.
The hESC-RPE cells (Regea08/017, Regea08/023 or Regea11/013) and hREC (ACBRI 181) were co-cultured
on opposite sides of transparent membranes for up to six weeks. Thereafter barrier function, small molecule
permeability, localization of RPE and endothelial cell marker proteins, cellular ﬁne structure, and growth factor
secretion of were evaluated.
After co-culture, the RPE speciﬁc CRALBP and endothelial cell speciﬁc von Willebrand factor were
appropriately localized. In addition, the general morphology, pigmentation, and ﬁne structure of hESC-RPE
cells were unaﬀected. Co-culture increased the barrier function of hESC-RPE cells, detected both with TEER
measurements and cumulative permeability of FD4 – although the diﬀerences varied among the cell lines. Co-
culturing signiﬁcantly altered VEGF and PEDF secretion, but again the diﬀerences were cell line speciﬁc.
The results of this study showed that co-culture with hREC aﬀects hESC-RPE functionality. In addition, co-
culture revealed drastic cell line speciﬁc diﬀerences, most notably in growth factor secretion. This model has the
potential to be used as an in vitro outer blood-retinal barrier model for drug permeability testing.
1. Introduction
Retina is a part of the central nervous system and thus protected by
a blood brain barrier analogue, blood retinal barrier (BRB), consisting
of inner (iBRB) and outer part (oBRB). oBRB consists of three layers:
retinal pigment epithelial cells (RPE), Bruch's membrane and choroidal
endothelial cells (CEC). RPE cells face the neural retina and are
connected to each other by tight junctions, forming a selective barrier.
RPE has several vitally important functions such as phagocytosis of
shed photoreceptor outer segments, vitamin A metabolism, regulation
of the transport of nutritive substances, absorption of stray light, and
control of retinal ion balance [1,2]. On the other side, oBRB is in
contact with the blood stream via the fenestrated CECs. Interactions
between RPE and CEC are vitally important for transporting nutrients
and water to the retina, and removing the metabolic waste to the blood
stream [2,3]. Between these two cell types lies a layered extracellular
matrix (ECM) structure - Bruch's membrane [4]. Besides oﬀering
support and separating RPE from the CEC, Bruch's membrane it is
also a playing ground of growth factors secreted by the RPE, such as
vascular endothelial growth factor (VEGF) and pigment epithelial
derived growth factor (PEDF). An imbalance in this homeostasis might
lead to dysregulation in angiostasis [5,6], for example to choroidal
neovascularization and age-related macular degeneration (AMD) [7].
Due to its excellent protective properties oBRB also acts as a barrier
to many drug molecules, making medical therapy of many retinal
diseases demanding. This is the case in diabetic retinopathy (DR),
AMD, posterior uveitis and retinitis pigmentosa [8]. For many decades
ocular drug delivery to posterior segments of the eye has been assessed
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with in vivo animal studies, but recently due to their high costs and
ethical considerations, alternative methods, such as ex vivo and in vitro
techniques have gained popularity [9]. Ex vivo cultures of isolated
tissues have been used to evaluate morphology, integrity and function
of oBRB [10–12]. In vitro models can provide a valuable pre-clinical
testing platform for disease modeling, testing nutrient/pharmaceutical
traﬃcking, as well as drug delivery and targeting [13,14]. In vitro
models based on primary RPE cell cultures of animal origin [14] have
been widely used, although they suﬀer from species-related applic-
ability problems. The functionality of oBRB has been extensively
studied only in RPE cells alone (referred onwards as RPE solo-culture),
generally using the immortalized RPE cell line ARPE-19 [14–17].
These RPE solo-cultures, however, do not develop cell-cell interactions
typical to native human RPE, thus several oBRB co-culture models
have been developed [7,18,19]. RPE cells have been co-cultured with
endothelial cells in “contacting” cultures as mixtures permitting direct
contact [20], sandwiched with ECM proteins [18,21], or cultured on
opposite sides of amniotic membrane [22] or Transwell inserts [23,24].
In addition, “non-contacting” co-cultures have been performed where
one cell type is cultured on top of a cell culture insert and the other cell
type on the bottom of the well plate [23–26]. These various oBRB
models have been generated either with primary RPE cells, which have
a limited availability, or with immortalized RPE cell lines which have
morphological and developmental abnormalities [9,27]. Thus, there is
a need for new ophthalmic in vitro models with closer resemblance to
the functionality and morphology of the native tissue [9,13]. RPE cells
derived from human embryonic stem cells (hESC) provide an unlimited
source of cells which closely resemble their native counterpart [28–34].
They have been shown to express RPE speciﬁc genes and proteins,
become highly pigmented and polarized, display several RPE speciﬁc
functions such as PEDF secretion and phagocytosis of photoreceptor
outer segments, and express functional membrane proteins important
for maintaining barrier properties [35,36]. When transplanted to
rabbits, hESC-derived RPE cell sheets restore ERG and outer nuclear
layer (ONL) thickness for a short period of time [37].
In this work we aimed to develop a hESC-RPE based contacting
oBRB co-culture model by utilizing three diﬀerent hESC lines. The
eﬀects of co-culture on hESC-RPE barrier properties were evaluated
with trans-epithelial electrical resistance (TEER) measurements and
permeability tests, the morphology with confocal and electron micro-
scopy and cellular functionality with growth factor secretion assays.
The results of this work could pave the way towards an in vitro model
that could be useful for drug delivery research and retinal disease
modeling.
2. Materials and methods
2.1. Cells
2.1.1. Endothelial cells
Human Umbilical Vein Endothelial Cells (HUVECs) were extracted
at BioMediTech, University of Tampere from the umbilical cords
acquired from scheduled Cesarean sections according to Hamilton
et al. [38]. HUVECs were cultured in HUVECmem: Gibco M199
medium (Life Technologies, Carlsbad, CA, USA) with 1% Gibco
GlutaMAX™ (Life Technologies), 2% Penicillin-Streptomycin (Lonza
Group Ltd., Basel, Switzerland), 10% fetal bovine serum (FBS Gold,
PAA, GE Healthcare Ltd., Little Chalfont, UK), 0.3% Endothelial Cell
Growth Supplement (First Link Ltd., Wolverhampton, UK), 0.08%
Fungizone amphoterizin B (Life Technologies) and 0.1% heparin
sodium salt from porcine intestinal mucosa (Sigma-Aldrich, St. Louis,
MO, USA). The HUVECs were routinely cultured on 5 μg/cm2 collagen
I (COLI, Sigma-Aldrich) coating, passaged at 80–90% conﬂuency and
used for experiments at passages 5–10.
Primary human retinal microvascular endothelial cells (hREC),
ACBRI 181, are a commercially-available cell line (Cell Systems,
Kirkland, WA, USA). The cells were grown on ECM Attachment
Factor™ (AF, Cell Systems). For the culture of ACBRI 181 a special
CSC medium was used, consisting of Complete Serum-Free Medium
with RocketFuel and antibiotic Bac-Oﬀ (Cell Systems), supplemented
with 10% fetal bovine serum (FBS Gold) and 1% penicillin-streptomy-
cin (Cambrex Bio Science, Walkersville, MD, USA). ACBRI181 were
used for experiments at passage 8.
Before the co-culture experiments the preference of cell culture
substrata of HUVEC and ACBRI181 cells was assessed by plating the
cells on COLI, collagen IV (COLIV, Sigma-Aldrich) and AF. Polystyrene
cell culture plates were coated with 5 μg/cm2 of ECM by incubating for
1–3 h at 37 °C. Thereafter the wells were brieﬂy washed with phos-
phate buﬀered saline (DPBS, Lonza Group Ltd.). Cells were washed
thrice with DPBS, dissociated with Trypsin-EDTA (Lonza Group Ltd.),
counted and passaged on top of coatings at a density of 100,000 cells/
cm2. Cells were cultured for two days and ﬁxed with 4% paraformal-
dehyde (PFA, Sigma-Aldrich) solution and subjected to the indirect
immunoﬂuorescence staining (below). These preliminary tests
(Supplemental Fig. 1) demonstrated that there was no marked
diﬀerence in the cell number on diﬀerent substrata. Thus the COLIV
which is routinely used for hESC-RPE cell culture [39], can also be
used for endothelial cells.
2.1.2. Human embryonic stem cell derived retinal pigment epithelial
cells
The hESC lines Regea11/013 (46, XY), Regea08/017 (46, XX) and
Regea08/023 (46, XY) established previously by our group in
University of Tampere, were used [40]. The undiﬀerentiated hESCs
were cultured similarly as previously described [41] at +37 °C in 5%
CO2 on human foreskin ﬁbroblast feeder cells (hFFs; 36,500 cells/cm
2;
CRL-2429™; ATCC, Manassas, VA, USA) which were mitotically
inactivated either with γ-irradiation (40 Gy) or mitomycin C (10 μg/
ml, Sigma-Aldrich), in serum-free conditions in Knock-Out Dulbecco's
Modiﬁed Eagle Medium (KO-DMEM) containing 20% Knock-Out
serum replacement (KO-SR), 2 mM Glutamax, 0.1 mM 2-mercap-
toethanol (all from Invitrogen, Carlsbad, CA, USA), 1% Minimum
Essential Medium nonessential amino acids, 50 U/ml penicillin/strep-
tomycin (both from Cambrex Bio Science), and 8 ng/ml human basic
ﬁbroblast growth factor (bFGF; R &D Systems Inc., Minneapolis, MN).
The culture medium was replenished ﬁve times a week.
Undiﬀerentiated colonies were passaged onto new feeder cells either
manually once a week or enzymatically at ten-day intervals with
TrypLE Select (Invitrogen).
Spontaneous RPE diﬀerentiation was induced by reducing KO-SR
concentration from 20% to 15% and removing bFGF from the hESC
culture medium. This modiﬁed medium is called RPEbasic. The hESC
colonies were manually dissected and cultured in suspension in low cell
bind six-well plates (Nalgene, NUNC, Tokyo, Japan), as ﬂoating
aggregates (embryoid bodies). The embryoid bodies were allowed to
mature for 48–109 days until suﬃcient pigmentation appeared,
changing the medium three times a week. The pigmented areas of
ﬂoating aggregates were manually selected, cut and subsequently
dissociated with Trypsin–EDTA. Acquired single cell suspensions were
ﬁltered through 100 µm BD Falcon cell strainer (BD Biosciences, San
Jose, USA), and cells were plated onto well plates coated with human
COLIV (5 g/cm2) to expand cell numbers and purify the cell popula-
tion. After expansion of this passage 2 for 65‒349 days, the hESC-RPEs
were dissociated with Trypsin–EDTA, ﬁltered through a strainer and
counted to be plated for experiments, in which the hESC-RPE cells
were in passage 3.
Cells secrete several soluble factors to the culture medium. The
human fetal RPE cell [42] and mature hESC-RPE cell [43] conditioned
media have previously been shown to induce neuronal cell diﬀerentia-
tion [42,43]. As in the native retinal tissue, the endothelial cells receive
soluble queues from RPE. Therefore, prior the co-culture experiments
we wished to test the ability of HUVEC (always between the passage 7
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and passage 9), and ACBRI181 (always passage 8) cells to grow in fresh
RPEbasic medium and RPEbasic conditioned by mature hESC-RPE
cells. The eﬀects were compared to the cultures where both endothelial
cell types were grown in their own media. Cells were cultured for 7 days
and new test media were changed every day. This preliminary test
suggested that endothelial cells prefer conditioned RPEbasic
(Supplemental Fig. 1) over the fresh RPEbasic medium. Therefore all
co-cultures were maintained in co-culture medium – 1:1 mixture of
hESC-RPE conditioned RPEbasic and fresh RPEbasic.
2.2. Treatment of polyethylene terephthalate substrata for the cell
culture
In order to have equal culture conditions for both cell types the
transparent polyethylene terephthalate (PET) membranes (Millipore
12 Well Millicell, 1.0 µm pore diameter; Merck Millipore, Billerica, MA,
USA) were removed from the supporting hanging culture inserts with a
scalpel and placed within Minusheet (part no. 1300, Minucells and
Minutissue-Vertriebs GmbH, Bad Abbach, Germany) carriers, which
were cleaned using EtOH (ﬁrst 10 min in 70% EtOH, then 5 min in
99.5% EtOH followed with drying) before use. Minusheet constructs
were coated with COLIV (5 µg/cm2), for 1 h at +37 °C, with the
membranes ﬂipped after 30 min to ensure that the coating was equal
on both sides. After coating, the membranes were washed once with
1xPBS. The PET membrane was always oriented similarly within the
Minusheet carrier, to ensure that all samples were uniform. All work
was carried out under the laminar ﬂow hood. The pilot tests revealed
that the endothelial cells had rather low adherence on the COLIV
coated PET membrane. Therefore we increased the amount of reactive
binding sites with plasma treatment. PET membranes with Minusheet
carriers were placed onto a 12-well plate, with the untreated side facing
up. The plasma treatment was carried out with O2 gas in Pico, Diener
Electronic (Ebhausen, Germany) using constant 0.4 mBar pressure and
50 W power for 1 min or with Reactive Ion Etcher (RIE Advanced
Vacuum Scandinavia AB, Sweden) with parameters 30 scm, 30 W
30 mtorr, 1 min). Thereafter Minusheet constructs were coated simi-
larly as without plasma treatment. The secondary pilot test exhibited
that plasma treatment increased the number of endothelial cells on
PET membrane after 9–10 days of culture (Supplemental Fig. 2).
2.3. Cell plating and maturation for co-culture
Human RECs and hESC-RPE cells were co-cultured with the
“contacting” method [23]. Both cell types were plated immediately
after coating of the Minusheet constructs with COLIV. First, the
endothelial cells (100,000 cells/cm2) were plated in 150 μl of CSC
medium, and were allowed to adhere at 37 °C, 5% CO2 for 4 h.
Thereafter the Minusheet carriers were ﬂipped, the CSC medium was
removed and the hESC-RPE cell suspension (100,000 cells/cm2) was
applied onto the other side of the membranes in RPEbasic. Then,
additional 500 μl of the co-culture medium was added to the con-
structs. After 4 h of incubation i.e. after hESC-RPE cells had attached
to the membrane surface, an additional 1.5 ml of the co-culture
medium was added.
The co-culture samples were allowed to mature for 4–6 weeks
(Regea08/017 36d ± 7d; Regea08/023 32d ± 4d and Regea11/013 34d
± 4d), changing the medium three times a week. The co-culture
medium was used during the ﬁrst three weeks, and pure RPEbasic
for the remaining time. The co-cultures were analyzed once the hESC-
RPE cells regained their pigmentation.
2.4. Trans-epithelial electrical resistance
The barrier properties of the solo-cultured and co-cultured samples
were evaluated with TEER measurements at the end of the maturation
period: Each sample, cultured on the PET insert placed to the
Minusheet carrier (Fig. 1A), was cut out (Fig. 1A). The culture insert
was cut to two pieces (Fig. 1B), and clamped to P2307 slider
(Physiologic Instruments, San Diego, CA, USA) (Fig. 1AB), placed into
a custom-made teﬂon chamber [36] ﬁlled with 1xPBS, and TEER was
measured with the Millicell ERS-2 Voltohmmeter (Merck Millipore)
(Fig. 1C). TEER values (Ω cm2) were calculated by subtracting the
TEER of a similarly treated substrata-coated PET membrane without
cells, and by multiplying the result by the surface area. TEER values
were obtained from ﬁve individual diﬀerentiation experiments with all
three diﬀerent hESC lines with multiple parallel samples, and two
technical replicates.
2.5. Permeability tests
After the TEER measurement, the samples in sliders P2307 were
placed into the Ussing Chamber device (EM-CSYS-8 (Physiologic
Fig. 1. The illustration how cells cultured for 4–6 weeks on PET ﬁlter insert clamped to Minusheet carrier was transferred to barrier function tests. After the 4–6 weeks of cell culture,
the ﬁlter insert with cells was cut out from the Minusheet carrier (A). In order to have two technical replicates, the insert was cut to two pieces (see arrows), and each one was placed to
one P2307 slider (B). The transepithelial electrical resistance was measured in a custom-made P2307 slider chamber (in the insert in C) with Millicell ERS-2 Voltohmmeter (C). The
sample was then placed to EM-CYS-8 Ussing chamber without the electrodes (D) for the permeability assay. After the assay the same cell samples were processed for
immunoﬂuorescence or electron microscopy.
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instruments)) with P2300 EasyMount Diﬀusion Chambers to measure
the barrier properties of the co-cultures (Fig. 1D). The permeability
assessments were carried out in 2.25 ml of RPEbasic without KO-SR
(thereafter referred to as Ussing medium) both on the donor and
acceptor side. On the donor side 1 mg/ml of 4 kDa ﬂuorescein
isothiocyanate–dextran (FD4, Sigma-Aldrich) was used as the test
molecule. Blank samples were collected prior to the test from both
donor and acceptor media. The pH in chambers was kept constant with
CO2 gas (5% CO2, 10% O2, 85% N2) bubbling. After 1 h, 2 h, 3 h and
4 h, two parallel 100 μl samples were taken from the acceptor side of
the chamber, and 200 μl of fresh medium was added to balance the
removed volume. Samples were analyzed with Wallac Victor2 1420
multilabel counter spectrophotometer (Turku, Finland).
The cumulative permeability i.e. the cumulative amount of ﬂuores-
cence appearing in the acceptor solution versus time, was calculated
from the average value of the two parallel absorbance measurement
values of the acceptor (basal side) from which subtracting the value of
pure Ussing medium (i.e. blank). This value was then divided by the
total volume of acceptor side. The dilution eﬀect of the added fresh
medium after every hour. This was calculated according to Pitkanen
et al. [44].
Cumulativepermeability Facceptor Fpure medium
medium vol ml
= ( − )
( )*)
F is the emitted ﬂuorescence value. Acceptor is in the beginning
devoid of ﬂuorescence, situated in chamber basal to hESC-RPE, apical
to EC. Pure medium is fresh medium without ﬂuorescence. (*) in
equation is the dilution eﬀect of fresh medium after every hour.
The cumulative amount permeated was calculated from cumulative
permeability by dividing by the spectrophotometer value of the
exposure medium and multiplied by 100%.
Cumulative permeability Cumulative permeability
F donor
% =
*100
The diﬀusion of the solutes across cell cultures was characterized by
calculating the apparent permeability coeﬃcient (Papp, cm/sec) ac-
cording to Pitkanen et al. [44], cumulative permeability of FD4 after
every hour was plotted, and the slope (kx+b) of the linear portion, was
divided with the surface area (0.031 cm2) multiplied with the spectro-
photometric value (i.e. maximum intensity) of the probe molecule in
the donor solution.
Permeability coefficient kx b
surface area cm F donor
= ( + )
( 2)*
Donor in the equation is the maximum intensity from the Ussing
medium that contains 1 mg/ml of FD4.
2.6. Indirect immunoﬂuorescence
After the permeability test, indirect immunoﬂuorescent staining
was performed in order to evaluate cell morphology, structure, and
polarity of the samples. All samples were ﬁrst washed with 1×PBS,
ﬁxed with 4% paraformaldehyde (Sigma-Aldrich) for 10 min at RT,
washed four times with 1×PBS, and permeabilized with 0.1% TritonX-
100 (Sigma-Aldrich) in 1×PBS for 10 min at RT. After that, the samples
were again washed repeatedly with PBS, and 3% bovine serum albumin
(BSA, Sigma-Aldrich) in PBS was added to the samples for 1–1.5 h at
RT, or overnight at 4 °C, to block the non-speciﬁc binding sites. Then,
the samples were incubated for 1–1.5 h at RT or overnight at 4 °C with
the primary antibodies in 0.5% BSA-PBS. The endothelial cells were
stained with rabbit-anti-von Willebrand factor (vWf, 1:500, Daco,
Glostrup, Denmark); hESC-RPE cells were stained with mouse-anti-
CRALBP (1:500, Abcam, Cambridge, UK). The tight junctions were
stained with mouse-anti-ZO-1 (1:250 Invitrogen), and ﬁlamentous
actin was stained with amanita phallotoxin Phalloidin 680 (1:200,
Sigma-Aldrich). The primary antibody incubations were followed by 4×
washes with 1×PBS. The secondary antibodies, donkey-anti-mouse and
goat-anti-rabbit (both from Life Technologies) were both used at
dilution of 1:1000 in 0.5% BSA-PBS. The secondary antibodies were
incubated for 1–1.5 h at RT. Finally, the samples were washed ×4 with
1×PBS mounted between two cover glasses with Vectashield® mount-
ing medium with 4′,5-diamidino-2-phenylindole (DAPI) (Vector
Laboratories Inc.). The visualization and imaging of the stained
samples was carried out with LSM 780 confocal microscope (Carl
Zeiss, Jena, Germany) using magniﬁcation of 40× and resolution of
1200×1200.
2.7. Enzyme-linked immunosorbent assay
The concentrations of secreted PEDF and VEGF were determined
using Chemikine PEDF Sandwich ELISA Kit (Millipore, Temecula, CA,
USA) and Quantikine VEGF ELISA Kit (R &D Systems), respectively,
according to the manufacturer's instructions.
2.8. Transmission electron microscopy
After 4–6 weeks of co-culture, the constructs were ﬁxed for 2 h at
RT with 2% glutaraldehyde (Electron Microscopy Sciences, Hatﬁeld,
PA, USA) in 0.1 M phosphate buﬀer, and washed with 0.1 M phosphate
buﬀer. The samples were post-ﬁxed with 1% osmium tetroxide (Ladd
Research, Williston, VT, USA) for 1 h at RT. The samples were then
dehydrated through an ordered acetone series: 70% acetone, 94%
acetone, and absolute acetone (J.T. Baker; Avantor Performance
Materials, B.V. Deventer, Netherlands). Thereafter the samples were
impregnated with 1:1 mixture of absolute acetone and epoxy resin
(Ladd Research) for 1.5 h at RT. The embedding of pure epoxy resin
was done overnight at RT, and polymerization of epoxy resin for 48 h at
60 °C. Thin sections were stained with 1% uranyl acetate for 30 min
and with 0.4% lead citrate (Fluk, Steinheim, Switzerland) for 5 min.
Samples were examined and imaged with JEM-2100F TEM (Jeol Ltd.,
Tokyo, Japan). The length of microvilli, cell thickness, and basal lamina
thickness were measured with Image J Image Processing and Analysis
Software from the TEM images.
2.9. Statistical analyses
The statistical signiﬁcance of TEER, permeability assay and ELISA
were analyzed with PASW Statistics, version18 with two tailed Mann-
Whitney U. The image analysis from TEM images was calculated with R
statistical computing and graphics program (version 3.3.1) (R
Foundation for Statistical Computing, Vienna, Austria Foundation for
R Foundation for Statistical Computing, Vienna, Austriatatistical
Computing, Vienna, Austria) with two-sample Wilcoxon rank sum test.
The number of replicates is indicated in the ﬁgure legends. Results
were considered signiﬁcant at p < 0.05.
2.10. Ethical issues
The extraction of HUVECs from the umbilical cords from full term
scheduled Cesarean sections has the supportive statement from the
Ethics Committee of Pirkanmaa Hospital District (Miettinen/R13019).
The National Authority for Medicolegal Aﬀairs Finland has given
approval to study human embryos (Dnro 1426/32/300/05) and we
have a supportive statement from the Ethics Committee of Pirkanmaa
Hospital District to derive hESC lines from early stage embryos that are
not used in infertility treatments (Skottman/R05116). No new hESC
lines were generated in this study.
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Fig. 2. Representative confocal ortho-images after 4–6 weeks of hESC-RPE solo-cultures (A-C, J-L) and hESC-RPE and ACBRI181 co-cultures (D-I, M-R) (n= 4, all with 2 biological
and 2 technical replicates). Samples were immunostained with RPE speciﬁc marker CRALBP (green) and endothelial cell speciﬁc von Willebrand factor (vWF, red) (A-I) or tight junction
marker ZO-1 (green) or ﬁlamentous actin binding phalloidin (red) (J-R). Nuclei were counterstained with DAPI (blue). ImagesD) Regea08/017, E) Regea08/023 and F) Regea11/0113
from the hESC-RPE level and G,H, and I from the endothelial level of the same co-cultures. Similarly imagesM) Regea08/017,N) Regea08/023 and O) Regea11/0113 from the hESC-
RPE level and P,Q and R from the endothelial level of the same co-cultures. Scale bars 10 µm.
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3. Results
3.1. Cell morphology
Expression and localization of cell type speciﬁc proteins was
evaluated using indirect immunoﬂuorescence after 4–6 weeks of co-
culture of hESC-RPE cells and ACBRI181 hRECs. Localization of
CRALBP, the RPE-speciﬁc protein, was similar in solo-cultured
hESC-RPEs (Fig. 2A, B, C) and co-cultured hESC-RPEs (Fig. 2D, E,
F). Also the endothelial cell speciﬁc vWF labeling localized to hRECs
(Fig. 2G, H, I) in co-cultures. As hRECs were visualized with the
confocal microscope through the pigmented hESC-RPE cells and
through the 1 µm pores in the PET membrane the intensity of the
label is slightly fainter on one side. The ZO-1 tight junction protein had
a similar appearance both in solo-cultured (Fig. 2J, K, L) and co-
cultured (Fig. 2M, N, O) hESC-RPEs.
The co-culture of hESC-RPE cells appeared to eﬀect on epithelial
culture: the endothelial cell soloculture had fewer islands than en-
dothelial cells co-cultured with hESC-RPE cells (Supplemental Fig. 3).
Also the endothelial cells cultured with Regea08/017 and Regea08/023
were more conﬂuent than those cultured with Regea11/013
(Supplemental Fig. 4 and Supplemental Fig. 5). The endothelial cells
and hESC-RPEs might interact with each other as seen in a confocal
image where endothelial cell has sent a vWF positive process though
the 1 µm pores of PET ﬁlter insert (Supplemental Fig. 6). In addition,
endothelial cells interacted with each other by forming capillary-like
structures which were visible in all cultures (white arrows in
Supplemental Fig. 4) and (white arrowhead in Supplemental Fig. 5).
Cell morphology and pigmentation of hESC-RPE cells were un-
aﬀected by the co-culture, as seen from the low magniﬁcation electron
microscopy images (Fig. 3A). During maturation and polarization the
RPE cells are known to adopt a more columnar shape, thus the hESC-
RPE cell height was quantiﬁed (Fig. 3B) for solo- and co-cultured
hESC-RPEs from TEM photographs (Table 1). We found that co-
culture signiﬁcantly decreased the cell height of Regea08/017 hESC-
RPE line (p=0.0014), but not Regea08/023 (p=0.331) or Regea11/013
(p=0.364) hESC-RPE cell lines.
During cell maturation and polarization the brush border is
developed on the apical side of RPE cells. Microvilli length was
quantiﬁed from TEM images of the solo- and co-cultured hESC-RPE
(Fig. 4A-C), (Table 2). In Regea08/023 hESC-RPE cells the brush
border was signiﬁcantly shorter in solo-cultures than in co-cultures (p
< 0.001). In Regea11/013 the microvilli were also slightly shorter in
solo-cultures than in co-cultures but this diﬀerence did not reach
statistical signiﬁcance (p = 0.058). Finally, due to several outliers in
Regea08/017 hESC-RPE, the diﬀerences were not statistically signiﬁ-
cant (p = 0.896). It should be noted that ultrathin sections (approx.
70 nm) do not capture the full length of the microvilli but rather a
projection of them in speciﬁc layers of the cross-section. However,
qualitatively, one can estimate that both the length and the number of
microvilli are increased in co-cultures.
The cell-cell interaction can aﬀect ECM organization and deposi-
tion. In all solo-cultures and co-cultures the deposited ECM had a
highly organized structure (Fig. 4D,E). Quantitation of the diﬀerences
would not give reliable results. Therefore, only the ECM thickness was
measured from TEM images of the solo- (Fig. 4D) and co-cultured
hESC-RPEs (Fig. 4E), (Table 3). The co-culture signiﬁcantly increased
the ECM deposition underneath the Regea11/013 hESC-RPE
(p=0.020). The diﬀerences were not statistically signiﬁcant for
Regea08/017 (p=0.443) or Regea08/023 (p=0.068) hESC-RPE cells.
3.2. Barrier properties
The integrity of mature cell cultures was ﬁrst analyzed via TEER
measurement immediately after cutting the insert from the Minusheet
carrier and placing it to the P2307 slider. This also ensured that the
cells were placed tightly on the slider. After the 4–6 weeks solo-culture,
ACBRI181 had reached the TEER of 3.9 Ωcm2 (Fig. 5A). Co-culture
with ACBRI181 endothelial cells signiﬁcantly increased TEER of
Regea08/023 hESC-RPE (p=0.013). For the other two cell lines,
although TEER was higher in co-culture, the diﬀerences were not
signiﬁcant due to high variation (p=0.059 for Regea08/017 and
p=0.310 for Regea11/013). When all the solo-cultures of the three cell
lines were compared to all the co-cultures, the overall diﬀerence in
TEER was statistically signiﬁcant (p = 0.002), (Fig. 5B). The TEER of
pristine PET ﬁlter insert without cells (0.3 cm2) analyzed with Millicell
ERS-2 Voltohmmeter prior cutting, was 45 Ω cm2−54 Ω cm2, whilst
the same clamped insert (0.031 cm2) with the same Millicell ERS-2
Voltohmmeter was 25 Ω cm2−29 Ω cm2. These results indicate that the
TEER was slightly compromised by cutting and clamping.
The tightness of the cultures was also evaluated by measuring
ﬂuorescent dye permeability in Ussing chamber for 4 h (Fig. 5C). The
cumulative permeability of the empty PET membrane increased from
0.036% to 1.94% in this time. For the ACBRI181 endothelial cells in
solo-culture the increase was from 0.26% to 1.47%. Co-culture with
ACBRI181 cells signiﬁcantly decreased the cumulative permeability of
Regea08/023 hESC-RPE (p=0.013). The diﬀerences for the other two
cell lines were not signiﬁcant (p=0.221 for Regea08/017 and p=0.445
for Regea11/013). Similarly to TEER values, when all solo-cultures of
the three cell lines were compared to all the co-cultures, the decrease in
cumulative permeability was statistically signiﬁcant (p = 0.018)
(Fig. 5D). The co-culture with ACBRI181 cells also decreased the
permeability coeﬃcient (10 −6 cm/sec) but that was not statistically
signiﬁcant Regea08/017 hESC-RPE (p = 0.17), Regea08/023 (p =
0.11) or Regea11/013 (p=0.73) (Fig. 5E). But when all solo-cultures of
the three cell lines were compared to all the co-cultures, the decrease in
cumulative permeability was statistically signiﬁcant (p = 0.036)
(Fig. 5F).
3.3. Growth factor secretion
Finally, we assessed how the co-culture of hESC-RPE cells with
ACBRI181 endothelial cells aﬀects growth factor expression.
ACBRI181 cells did not secrete detectable PEDF (Fig. 6A), as expected,
and only secreted 0.56 ng/ml VEGF (Fig. 6B). PEDF secretion was
signiﬁcantly higher in co-cultured Regea08/017 (p = 0.00004) and
Regea08/023 (p = 0.000005) hESC-RPE cells, but not in Regea11/013
hESC-RPE. VEGF expression, on the other hand, was signiﬁcantly
higher in co-cultured Regea08/017 and Regea11/13 hESC-RPE
(p=0.032 and p=0.014, respectively), but lower for co-cultured
Regea08/023 hESC-RPE (p=0.025).
4. Discussion
In vitro modeling of healthy functional RPE requires a polarized
and mature monolayer of RPE cells characterized by strong barrier
properties and low permeability [23]. In addition, these RPE cell
cultures should function similarly to native cells. Cell culture methods
should be consistent and eﬃcient, yielding high quality cell populations
with little variation between batches. Primary cells extracted from
tissue tend to diﬀer from isolate to isolate and the yield is always rather
low [9]. Immortalized RPE cell lines provide a high yield, but they lack
some of the characteristics, gene, and protein expression, critical to cell
functions normally observed in RPE [45]. Human ESCs oﬀer a solution
to the limitations of primary and immortalized cell lines – they provide
an unlimited source of RPE cells, which have many functionally
important characteristics common to native RPE cells [28–33].
Previously, hESC-RPE cells have been used for in vitro modeling of
oBRB in solo-cultures [28,36,46]. To our knowledge our study is the
ﬁrst to demonstrate the use of hESC-RPE co-cultured with hRECs as a
potential in vitro model of oBRB.
In our earlier studies, we have shown that diﬀerentiated hESC-RPE
H. Skottman et al. Experimental Cell Research 359 (2017) 101–111
106
cell cultures adopt cobblestone morphology, express RPE speciﬁc
proteins and localize them correctly in solo-cultures [41,47]. The
present study shows that co-culturing hESC-RPE cells with endothelial
cells yield similar cobblestone morphology and localization of the RPE-
speciﬁc protein CRALBP. Also, expression and localization of vWF in
hRECs was unaltered in these co-cultures. There is no published
corresponding data, but the results are in accordance with the data
previously reported in ARPE-19 co-cultured with HUVECs [22,48].
ARPE-19 cell line, however, has important dissimilarities with human
primary RPE cell cultures, most importantly low or lacking pigmenta-
tion and polarization [22,49]. In our study, co-culturing hESC-RPE
cells with ACBRI181 did not aﬀect either cell pigmentation or overall
cell morphology. Co-cultured hESC-RPE had high amounts of pigmen-
tation, visible tight junctions, thick brush border and highly organized
ECM. Although there were diﬀerences in cell height, microvilli length
and ECM thickness, these all were within the range of expected
biological variation.
The queues from endothelial cells alter RPE cell functions [3], and
biological solutes they secrete modify RPE barrier function in co-
cultures [22,50]. Human CECs and RECs secrete diﬀerent solutes [51],
and for the purpose of an oBRB model hCECs would likely be the
optimal choice. However, according to our current knowledge hRECs
are commercially available, while hCECs are not. Primary bovine RPE
have previously shown to have higher TEER in solo-culture than in
contacting and non-contacting co-cultures with endothelial cells [50],
but human fRPE and primary EC co-cultures had higher TEER than
fRPE soloculture [52]. On the other hand, co-culturing ARPE-19 with
HUVEC for 4 weeks on opposite sides of polyester membranes
increased TEER [48]. In our study, co-culturing hESC-RPEs with
hRECs clearly increased TEER, although the diﬀerence was only
signiﬁcant for one of the three cell lines. When the tightness of the
cultures was evaluated by assessing the leakage or ﬂux of small
molecules from donor to acceptor side of the culture, all our cell lines
demonstrated decreased permeability in co-cultures. Similar ﬁndings
Fig. 3. A) The transmission electron micrographs after 4–6 weeks of hESC-RPE solo-cultures or hESC-RPE and ACBRI181 co-cultures (n= 3 with 2 biological replicates). Order from
top to bottom: hESC-RPE cells, PET membrane, and in co-cultures hRECs. From left to right: Regea08/017 solo-culture; Regea08/017+ACBRI101 co-culture; Regea08/023 solo-
culture; Regea08/023+ACBRI181 co-culture; Regea11/013 solo-culture; and Regea11/013+ACBRI181 co-culture. Scale bars 10 µm. B) The height of hESC-RPE cells was measured
from the micrographs using Image J analysis software and presented as box plots. The thicker lines indicate medians. Statistical signiﬁcance p < 0.05 is indicated with *.
Table 1
The hESC-RPE cell heights measured from the TEM photographs.
Culture number of samples total number of measurements range median statistical significance solo- vs. co-culture
Regea 08/017 2 6 18.00 µm - 20.09 µm 19.54 µm p=0.0014
Regea 08/017+ACBRI181 9 28 10.12 µm - 17.82 µm 14.65 µm
Regea 08/023 10 23 6.67 µm - 18.49 µm 9.16 µm p=0.3311
Regea 08/023+ACBRI181 9 32 7.88 µm - 12.33 µm 9.27 µm
Regea 11/013 2 8 15.37 µm - 19.28 µm 16.57 µm p=0.3638
Regea 11/013+ACBRI181 5 10 10.50 µm - 19.99 µm 17.95 µm
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have been reported previously with ARPE-19 and HUVEC co-cultures
[22] and primary bovine [50] RPE or primary human RPE [52] and EC
co-cultures. The permeation coeﬃcient (Papp) of the FD4 through co-
cultures was 10 times higher (2.93 + 10−6 cm/s) than though bovine
RPE-choroid (2.36 × 10−7 cm/s) [44], but still the co-culture was 2
times tighter than hESC-RPE solocultures (5.64 + 10−6 cm/s). The
increase in TEER and decrease in permeability indicates that hRECs
improve the barrier functions of RPE at least in vitro. This is also
important to recognize when these in vitro assays are used for
permeability and transport analysis of drugs or other molecules.
The balance of PEDF and VEGF levels is important for retinal
homeostasis as it stimulates endothelial cell migration and RPE
maturation [53,54]. In the developing retina PEDF is a diﬀerentiating
factor for RPE cells. However, in mature retina PEDF is a trophic factor
Fig. 4. The transmission electron micrographs after 4–6 weeks of hESC-RPE solo-cultures or hESC-RPE and ACBRI181 co-cultures (n= 3 with 2 biological replicates). A)
Representative images of the apical brush border of solo-cultured hESC-RPE cells, and (B) hESC-RPE+ ACBRI181 co-cultures. Scale bar 1 µm. (C) The length of apical microvilli of
hESC-RPE cells measured from the micrographs using Image J analysis software and presented as box plots (C). The thicker lines indicate medians. Statistical signiﬁcance was analyzed
but not found. D) Representative image of ECM underneath solo-cultured hESC-RPE cells, and (E) hESC-RPE+ ACBRI181 co-cultures. Scale bar 1 µm. (F) The height of hESC-RPE cells
was measured from the micrographs using Image J analysis software and presented as box plots. The thicker lines indicate medians. Statistical signiﬁcance p < 0.05 is indicated with *.
Table 2
The microvillus lengths in hESC-RPE cells measured from the TEM photographs.
Culture number of samples total number of measurements range median statistical significance solo- vs. co-culture
Regea 08/017 2 7 0.78 µm - 2.02 µm 1.20 µm p=0.8956
Regea 08/017+ACBRI181 13 51 0.71 µm - 8.49 µm 1.16 µm
Regea 08/023 11 36 0.49 µm - 1.92 µm 1.03 µm p=0.0002
Regea 08/023+ACBRI181 11 54 0.75 µm - 2.15 µm 1.39 µm
Regea 11/013 5 14 0.50 µm - 2.86 µm 1.395 µm p=0.0580
Regea 11/013+ACBRI181 5 14 0.86 µm - 2.47 µm 1.53 µm
Table 3
The ECM thickness underneath hESC-RPE cells measured from the TEM photographs.
Culture Number of samples Total number of measurements Range Median Statistical significance solo- vs. co-culture
Regea 08/017 2 6 0.97−1.25 µm 1.13 µm p = 0.4434
Regea 08/017+ ACBRI181 11 40 0.23−5.67 µm 1.04 µm
Regea 08/023 14 54 0.31−0.82 µm 0.58 µm p = 0.0676
Regea 08/023+ ACBRI181 13 51 0.48−2.24 µm 1.21 µm
Regea 11/013 7 30 0.48−3.02 µm 1.09 µm p = 0.020
Regea 11/013+ACBRI181 5 20 0.33−4.86 µm 2.22 µm
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Fig. 5. A) The barrier properties of after 4–6 weeks of hESC-RPE solo-cultures of hESC-RPE and ACBRI181 co-cultures (n= 3, with 2 biological and 2 technical replicates. Data are
expressed as mean +/-SD). (A) TEER values from individual cell lines as solo-cultures of endothelial cells, solo-cultures of hESC-RPEs, and hESC-RPE+ACBRI181 co-cultures, and (B)
pooled cell lines, ** p < 0.01; *** p < 0.001. Cumulative permeability % of 4 kDa Fitc dextran (FD4, Sigma-Aldrich, Germany) of solo- and co-cultures after the 4–6 weeks culture (n= 3,
with 2 biological and 2 technical replicates) in individual cell lines in solo- and co-cultures from 60 min to 240 min (C), and (D) in pooled cell lines at the 240 min time-point. Data are
expressed as mean+/-SD, * p < 0.05; *** p < 0.001. Permeability of FD4 expressed as permeability coeﬃcient (10−6 cm/s) (n= 3, with 2 biological and 2 technical replicates. Data are
expressed as mean +/-SD) (E) from individual cell lines and in pooled cell lines, * p < 0.05.
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for RPE, which also keeps CECs quiescent [53]. PEDF secretion of RPE
cells has been shown to be high in fetal RPE cells and hESC-RPE cells,
but very low in ARPE-19 cells [41,55,56]. In a previous study, co-
culture of dermal ECs with ARPE-19 induced a small, but statistically
signiﬁcant reduction in PEDF gene expression in ARPE-19 cells [20].
We have previously demonstrated that in hESC-RPE solo-cultures,
PEDF secretion increases during maturation and polarization of RPE
monolayer [41]. In this study, 48 h co-culturing of hESC-RPE cells with
hRECs increased PEDF secretion in two of the three cell lines
compered to solo-cultures. This reﬂects the inherent heterogeneity of
hESC-RPE cell lines which has been shown previously [47,57].
VEGF is a chemotactic and angiogenic factor which is secreted by
RPE cells in the retina [23,54]. VEGF is also an important pathologic
factor in vaso-proliferative disorders, such as AMD [7]. In previous
studies co-culture of RPE cells with ECs was shown to induce VEGF
secretion [20,22,23,50]. The 48 h/72 h co-culture with CECs or 24-h
co-culture with dermal ECs induced VEGF gene expression and VEGF
secretion in ARPE-19 cells [58]. Similarly to PEDF, the eﬀect of co-
culturing of hESC-RPEs with hRECs seems to be cell line speciﬁc – for
two cell lines, VEGF secretion increased as a result of co-culture, but
decreased for the third cell line. This further illustrates the hetero-
geneity of hESC-RPE cell lines.
In this study which according to our knowledge is the ﬁrst one in
which hESC-RPE cells were co-cultured with with hRECs for up to six
weeks, we show that does not alter RPE cell morphology or pigmenta-
tion, but increases the barrier properties. Co-culture also revealed cell
line speciﬁc diﬀerences in induction of growth factor secretion and in
hESC-RPE ﬁne structure. Although this model is still quite preliminary,
this data presented here propose that after critical selection of cell lines
and careful validation process co-culture methods could be to be a
valuable tool to model in vitro oBRB for drug permeability testing.
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